نتایج جستجو برای: 177lu dotatate

تعداد نتایج: 1456  

2013
Bhagwant Rai Mittal Kanhaiyalal Agrawal Jaya Shukla Anish Bhattacharya Baljinder Singh Ashwani Sood Anil Bhansali

Introduction: Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms, majority of which express somatostatin (SST) receptors. Recently, with the widespread use of positron emission tomography/computed tomography (PET/CT) and development of novel PET tracers like Ga-68 DOTA peptide which specifically bind to somatostatin receptors (SSTR), Ga-68 DOTA peptide PET/CT is used in manageme...

Journal: :international journal of endocrinology and metabolism 0
santosh kumar gupta department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected]; department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected] suhas singla department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected] nishikant a damle department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected] krishankant agarwal department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected] chandersekhar bal department of nuclear medicine, all india institute of medical sciences, india +91-1126593530, [email protected]

abstract men-i is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. we present a case of men-i syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating men-i.

2017
Benjamin G Challis Andrew S Powlson Ruth T Casey Carla Pearson Brian Y Lam Marcella Ma Deborah Pitfield Giles S H Yeo Edmund Godfrey Heok K Cheow V Krishna Chatterjee Nicholas R Carroll Ashley Shaw John R Buscombe Helen L Simpson

OBJECTIVE In adults with hyperinsulinaemic hypoglycaemia (HH), in particular those with insulinoma, the optimal diagnostic and management strategies remain uncertain. Here, we sought to characterise the biochemical and radiological assessment, and clinical management of adults with HH at a tertiary centre over a thirteen-year period. DESIGN Clinical, biochemical, radiological and histological...

2004
Nicola Fazio Silvana Del Vecchio Luigi Camera Giovanni Storto Marco Salvatore R H Reznek Gian Andrea Rollandi Ennio Biscaldi

Neuroendocrine tumours (NETs) are very rare diseases characterised by a high degree of histological and clinical heterogeneity. They can be silent (even producing some hormones) or clinically evident as a result of local growth and/or hormonal production. The diagnostic and therapeutic approach to patients with NETs should be multidisciplinary. A medical oncologist should coordinate a group of ...

2016
Johanna Svensson Tobias Rydén Linn Hagmarker Jens Hemmingsson Bo Wängberg Peter Bernhardt

BACKGROUND (177)Lu-DOTATATE is a valuable treatment option for patients with advanced neuroendocrine tumours overexpressing somatostatin receptors. Though well tolerated in general, bone marrow toxicity can, besides renal exposure, become dose limiting and affect the ability to sustain future therapies. The aim of this study was to develop a novel planar image-based method for bone marrow dosi...

Journal: :Journal of Nuclear Medicine Technology 2021

Metaiodobenzylguanidine (MIBG) imaging has been the standard for neuroblastoma staging many decades. Novel agents such as 18F-DOPA and 68Ga-DOTATATE are being used nowadays in academic centers. During coronavirus disease 2019 (COVID-19) pandemic, procurement of 123I-MIBG proved particularly challenging, necessitating use PET. is Food Drug Administration–approved...

2014
Rebecca A Dumont Daniela Seiler Nicolas Marincek Philippe Brunner Piotr Radojewski Christoph Rochlitz Jan Müller-Brand Helmut R Maecke Matthias Briel Martin A Walter

We aimed to explore the effects of 90Y-DOTATOC and 90Y-DOTATOC plus 177Lu-DOTATOC on survival of patients with metastasized gastrinoma. Patients with progressive metastasized gastrinoma were treated with repeated cycles of 90Y-DOTATOC or with cycles alternating between 90Y-DOTATOC and 177Lu-DOTATOC until tumor progression or permanent toxicity. Multivariable Cox regression analyses were used to...

Journal: :asia oceania journal of nuclear medicine and biology 0
samaneh zolghadri nuclear science and technology research institute (nstri), tehran, iran hassan yousefnia nuclear science and technology research institute (nstri), tehran, iran amir reza jalilian nuclear science and technology research institute (nstri), tehran, iran mohammad ghannadi-maragheh nuclear science and technology research institute (nstri), tehran, iran

objective(s): recently, bone-avid radiopharmaceuticals have been shown to have potential benefits for the treatment of widespread bone metastases. although 177lutriethylene tetramine hexa methylene phosphonic acid (abbreviated as 177lu- tthmp), as an agent for bone pain palliation, has been evaluated in previous studies, there are large discrepancies between the obtained results. in this study,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید